These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18568538

  • 1. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW.
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [Abstract] [Full Text] [Related]

  • 2. [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].
    Shao G, Wang J, Zhou K, Yan Z.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):170-3. PubMed ID: 12113668
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 4. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, Wu W, Qiu LW, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, Nabika T, Nagasue N.
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [Abstract] [Full Text] [Related]

  • 6. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G, Zhang WM, Zhang M, Xie D, Guo AL, Wen JM.
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [Abstract] [Full Text] [Related]

  • 7. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY, Lin ZY, Chuang WL.
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [Abstract] [Full Text] [Related]

  • 8. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
    Leelawat K, Laisupasin P, Kiatdilokrut A, Pongtongpool T, Narong S, Samkhumphim N, Ket-Horm S.
    J Med Assoc Thai; 2008 Oct; 91(10):1539-43. PubMed ID: 18972897
    [Abstract] [Full Text] [Related]

  • 9. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP, Yang SR, Xiao EH, Zhou SK, Zhang ZS, Liang ZY.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
    [Abstract] [Full Text] [Related]

  • 10. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP, Yu WS, Wei W.
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [Abstract] [Full Text] [Related]

  • 11. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J, He X, Lin X, Zhang C, Li J.
    Chin Med J (Engl); 2000 May; 113(5):446-8. PubMed ID: 11776102
    [Abstract] [Full Text] [Related]

  • 12. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    J Surg Oncol; 2008 Oct 01; 98(5):349-57. PubMed ID: 18646041
    [Abstract] [Full Text] [Related]

  • 14. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG, Gu WZ, Zhou YB, Tang HF, Li MJ, Ma WX.
    Eur J Clin Invest; 2008 Dec 01; 38(12):931-8. PubMed ID: 19021718
    [Abstract] [Full Text] [Related]

  • 15. [Mechanism of inhibition of tumor angiogenesis by Bletilla colloid: an experimental study].
    Feng GS, Li X, Zheng CS, Zhou CK, Liu X, Wu HP.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):412-6. PubMed ID: 12820920
    [Abstract] [Full Text] [Related]

  • 16. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 10; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 17. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
    Li Q, Xu B, Fu L, Hao XS.
    J Exp Clin Cancer Res; 2006 Sep 10; 25(3):403-9. PubMed ID: 17167981
    [Abstract] [Full Text] [Related]

  • 18. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH, Lee WJ, Lim HK, Lim JH.
    J Comput Assist Tomogr; 2007 Sep 10; 31(2):198-203. PubMed ID: 17414753
    [Abstract] [Full Text] [Related]

  • 19. [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor].
    Ren ZG, Lin ZY, Xia JL, Zhang BH, Ye SL, Chen SY, Gan YH, Wu XF, Chen Y, Ge NL, Wu ZQ, Ma ZC, Zhou XD, Fan J, Qin LX, Ye QH, Sun HC, Zhou J, Tang ZY.
    Zhonghua Zhong Liu Za Zhi; 2004 Feb 10; 26(2):116-8. PubMed ID: 15059334
    [Abstract] [Full Text] [Related]

  • 20. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC, Zheng SS, Wan YL, Jia CK, Xie HY.
    Hepatobiliary Pancreat Dis Int; 2003 Nov 10; 2(4):529-36. PubMed ID: 14627514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.